ArticleCancer immunology, immunotherapy : CII2017

The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients.

Heriberto Prado-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.